Contact our breast care nurses
0808 800 6000
The National Institute for Health and Care Excellence (NICE) has today (20 April 2021) announced its decision to recommend breast cancer drug...
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now said: “As lockdown restrictions ease in England, and we look ahead to a ‘...
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “Approval of Phesgo1 being used on the NHS in England...
Responding to a new study into the treatment of early breast cancer in the UK, between March and May 2020, led by the University of Manchester and...
A new study funded by the World Cancer Research Fund (WCRF) examined people’s exposure to modifiable risk factors using data from the Health...
NHS England cancer waiting times data from January 2021 (published on Thursday 11 March 2021) shows: The two week wait target for people...
Dr Simon Vincent, Director of Research, Support and Influencing at Breast Cancer Now said: “For people with breast cancer, having certain...
The National Institute for Health and Care Excellence (NICE) has today (Friday 26 February 2021) announced its decision to approve ribociclib with...
The National Institute for Health and Care Excellence (NICE) has today (Friday 12 February 2021) announced its decision to provisionally not...
Stay in touch
We’d love to keep in touch about news, events and how you can get involved. To hear from us, enter your email address below.
Connect with us
